Additionally, a considerable trend toward significance was observed in PFI between GSscan HRD-positive and GSscan HRD-negative in our clinical ovarian cancer cohort ( p = 0.085, Log-rank test, Fig. 5 C).
← all excerpts
A deep-learning-based genomic status estimating framework for homologous recombination deficiency detection from low-pass whole genome sequencing.
1
0.0850
0.0850